Role of heat treatment in childhood cancers: Distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy

Pediatric Blood and Cancer

Volumn 45, Issue 5, 2005, Pages 663-669

  Debes, Anette ^a   Willers, Reinhart ^a   Göbel, Ulrich ^a   Wessalowski, Rüdiger ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chemosensitivity; Pediatric tumors; Thermosensitivity; XTT assay

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FORMAZAN; GYRASE INHIBITOR; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL SURVIVAL; CHEMOSENSITIVITY; CHILDHOOD CANCER; COLORIMETRY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; EWING SARCOMA; GERM CELL TUMOR; HEAT STRESS; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; NEUROBLASTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; CROSS-LINKING REAGENTS; DNA TOPOISOMERASES, TYPE II; ETOPOSIDE; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROBLASTOMA;

EID: 24644474486     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20266     Document Type: Article

References (35)

1. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-4833.
2. Skipper HE, Schabel FM, Jr., Wilcox WS. Experimental evaluation of potential anticancer agents. Xiii. On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother Rep 1964;35:1-111.
3. Foote M. The importance of planned dose of chemotherapy on time: Do we need to change our clinical practice? Oncologist 1998;3:365-368.
4. Burdach S, Meyer-Bahlburg A, Laws HJ, et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing tumors: Results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003;21:3072-3078.
5. Ladenstein R, Philip T, Gardner H. Autologous stem cell transplantation for solid tumors in children. Curr Opin Pediatr 1997;9: 55-69.
6. Atra A, Pinkerton R. Autologous stem cell transplantation in solid tumours of childhood. Ann Med 1996;28:159-164.
7. van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002;13:1173-1184.
8. Jones EL, Samulski TV, Dewhirst MW, et al. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003;98:277-282.
9. Issels RD, Schlemmer M. Current trials and new aspects in soft tissue sarcoma of adults. Cancer Chemother Pharmacol 2002; 49:4-8.
10. Wessalowski R, Schneider DT, Mils O, et al. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Padiatr 2003;215:303-309.
11. Wessalowski R, Kruck H, Pape H, et al. Hyperthermia for the treatment of patients with malignant germ cell tumors: A phase I/II study in ten children and adolescents with recurrent or refractory tumors. Cancer 1998;82:793-800.
12. Wessalowski R, Van Heek-Romanowski R, Issels RD, et al. Estimated number of children with cancer eligible for hyperthermia based on population- and treatment-related criteria. Int J Hyperthermia 1999;15:455-466.
13. van Valen F, Winkelmann W, Jurgens H. Expression of functional Y1 receptors for neuropeptide Y in human Ewing sarcoma cell lines. J Cancer Res Clin Oncol 1992;118:529-536.
14. Estlin EJ, Veal GJ. Clinical and cellular pharmacology in relation to solid tumours of childhood. Cancer Treat Rev 2003;29:253-273.
15. Peng B, English MW, Boddy AV, et al. Cisplatin pharmacokinetics in children with cancer. Eur J Cancer 1997;33:1823-1828.
16. Balis FM, Holcenberg JS, Poplack DG. General principles of chemotherapy. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven; 1997. pp 215-275.
17. Asaumi J, Higuchi Y, Murakami J, et al. Thermoradiotherapy in human head and neck squamous cell carcinoma cell lines. Int J Mol Med 2002;10:287-291.
18. Ryu S, Brown SL, Kim SH, et al. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996;34:133-138.
19. Li WX, Franklin WA. Radiation- and heat-induced apoptosis in PC-3 prostate cancer cells. Radiat Res 1998;150:190-194.
20. Asea A, Ara G, Teicher BA, et al. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int J Hyperthermia 2001;17: 347-356.
21. Mivechi NF, Ouyang H, Monson JM, et al. Correlation of heat resistance and HSP-70A mRNA levels in human tumor cells measured by competitive quantitative polymerase chain reaction. Int J Radiat Oncol Biol Phys 1994;30:141-149.
22. Calderwood SK, Asea A. Targeting HSP70-induced thermotolerance for design of thermal sensitizers. Int J Hyperthermia 2002; 18:597-608.
23. Debes A, Oerding M, Willers R, et al. Sensitization of human Ewing tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res 2003;23:3359-3366.
24. Goebel U, Calaminus G, Schneider DT, et al. Management of germ cell tumors in children: Approaches to cure. Onkologie 2002;25: 14-22.
25. McPake CR, Tillman DM, Poquette CA, et al. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status. Oncol Res 1998;10: 235-244.
26. Fulda S, Honer M, Menke-Moellers I, et al. Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro. Eur J Cancer 1995;31A:616-621.
27. Hettinga JV, Konings AW, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia-a review. Int J Hyperthermia 1997;13:439-457.
28. Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999;15:79-107.
29. Engelhardt R. Hyperthermia and drugs. Recent Results Cancer Res 1987;104:136-203.
30. Ohtsubo T, Igawa H, Saito T, et al. Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42 degrees C and cisplatin. Radiat Res 2001;156:103-109.
31. Schulte JH, Schramm A, Pressel T, et al. Microarray-analysis: A new approach to study the molecular mechanisms of thermochemotherapy. Klin Padiatr 2003;215:298-302.
32. Hirohashi Y, Hidaka K, Sato S, et al. Biomodulation by hyperthermia of topoisomerase II-targeting drugs in human colorectal cancer cells. Jpn J Cancer Res 1995;86:1097-1105.
33. Van Heek-Romanowski R, Putter S, Trarbach T, et al. Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia. Med Pediatr Oncol 2001;36:197-198.
34. Dynlacht JR, Wong RS, Albright N, et al. Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes. Cancer Res 1994;54:4129-4137.
35. Kampinga HH. Hyperthermia, thermotolerance and topoisomerase II inhibitors. Br J Cancer 1995;72:333-338.